Clinical TrialsSearch results
Number of results: 535
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A clinical trial of Hochuekkito for patients with Long COVID
- Long COVID
- Tokumasu Kazuki
- 2024-05-15
Recruiting
- A Feasibility Study of Case Management by Psychiatric Care Providers to Improve Access to Cancer Screening for Patients with Schizophrenia in Usual Clinical Practice
- Schizophrenia (including Schizoaffective disorder), Cancer
- Fujiwara Masaki
- 2022-06-04
Recruiting
- A method for discriminating pleural adhesions using lung sound analysis.
- Pleural adhesion
- Toyooka Shinichi
- 2024-04-22
Recruiting
- A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
- Systemic Lupus Erythematosus
- Otani Tetsuya
- 2023-09-14
Recruiting
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjogren Syndrome With Moderate-to-Severe Symptom State
- Sjogren Syndrome
- Shimoyama Michio
- 2024-05-13
Recruiting
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjogren Syndrome With Moderate-to-severe Systemic Disease Activity
- Sjogren Syndrome
- Shimoyama Michio
- 2024-03-12
Recruiting
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Breast Cancer
- Inoguchi Akihiro
- 2024-02-21
Recruiting
- A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia
- Primary immune thrombocytopenia
- Yamauchi Kyosuke
- 2023-02-09
Recruiting
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Non-Small Cell Lung Cancer (NSCLC)
- Nakatani Iwami
- 2023-12-06
Recruiting
- A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo1)
- 2L+ NSCLC with KRAS G12C positive
- Venice Archer
- 2024-08-19